GeneGo has tapped Richard Brennan as director of toxicology, a role that will include running the MetaTox Consortium, a public/private systems biology collaborative, the company said last week.
Brennan previously was director of molecular and investigative toxicology at Iconix Biosciences, an associate director of pharmacology and cell biology at Cornerstone Pharmaceuticals, and a senior scientist at OSI Pharmaceuticals.